SI SEC InsiderScreener
‹ Screener

GLOBUS MEDICAL INC

GMED · Surgical & Medical Instruments & Apparatus · 135.7M shares · +3%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: $173M (gross $226M, SBC $53M)

Reference price $80.76 · est. market cap ~$11.0B — last insider sale, 2026-06-05 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

A80

Spine/ortho device leader (post-NuVasive) — profitable with strong FCF and an earnings inflection.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $745M2025-09-30 · $769M2025-12-31 · $826M2026-03-31 · $760M

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
67.4%
Operating margin
16.3%
Net margin
18.3%
Return on equity
11.8%
Return on assets
10.1%
Revenue growth (QoQ)
-8.1%
Net-income growth
422.3%
Current ratio
4.3×
Free cash flow
$589M
EBITDA
$757M
Tangible book value
$2.4B
Cash & investments
$629M
Stock comp / revenue
1.7%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-05Davidar David DOption exercise25K$26.27
2026-06-05Davidar David DSell25K$80.76
2026-06-04RHOADS ANN DOption exercise25K$26.27
2026-02-25Huller KellyOption exercise20K$43.58
2026-02-25Huller KellySell20K$94.50
2026-02-12Huller KellyOption exercise10K$45.64
2026-02-12Huller KellySell10K$87.67
2026-01-08Kline KyleOption exercise3.6K$51.87
2026-01-08Kline KyleSell3.6K$101.10
2026-01-08Norwalk Leslie VSell2.0K$101.10
2025-12-12Norwalk Leslie VSell4.0K$88.85
2025-12-08Paul David COption exercise34K$25.52
2025-12-01Kline KyleOption exercise4.9K$63.68
2025-12-01Kline KyleOption exercise3.6K$53.14
2025-12-01Kline KyleOption exercise5.0K$56.43
2025-12-01Kline KyleOption exercise5.0K$64.44
2025-12-01Kline KyleSell19K$90.00
2025-11-25Huller KellyOption exercise7.5K$25.96
2025-11-25Huller KellySell7.5K$90.00
2025-11-12Davidar David DOption exercise25K$25.52
2025-11-12Davidar David DSell25K$86.00
2025-11-11ZARRILLI STEPHEN TSell25K$84.29
2025-11-11ZARRILLI STEPHEN TOption exercise25K$44.14
2025-11-10RHOADS ANN DSell2.0K$85.00
2025-11-07RHOADS ANN DSell8.0K$81.00
2025-09-15RHOADS ANN DSell10K$58.46
2025-02-28RHOADS ANN DSell7.5K$78.68
2025-01-10Pfeil Keith WSell1.7K$89.17
2025-01-10Pfeil Keith WOption exercise5.8K$49.65
2025-01-10Pfeil Keith WOption exercise8.3K$53.27
2025-01-10Pfeil Keith WSell13K$88.17
2025-01-02Davidar David DGift6.1K—

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

TrialTitlePhaseStatusPrimary completion
NCT06298812 ↗REFLECT Scoliosis System Post Approval Study
Idiopathic Scoliosis
NARecruiting2027-03-31
NCT07589023 ↗A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis
Idiopathic Scoliosis
—Not Yet Recruiting2027-01-30
NCT04088383 ↗Amnios™ RT Outcomes Study
Plantar Fasciitis
NACompleted2022-11-30
NCT04257279 ↗Prospective Robotic Global Research Study (PROGRESS)
Lumbar Disc Disease
NAUnknown2021-12-01
NCT03162666 ↗Patient Outcomes Using an Expandable Spacer
Degenerative Disc Disease
—Withdrawn2020-11-06
NCT01861899 ↗Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK
Joint Dysfunction
—Completed2018-07-05
NCT03371316 ↗Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomies
Hemicraniectomies
NAWithdrawn2018-01-30
NCT00401518 ↗A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis
Lumbar Spinal Stenosis
NACompleted2017-08-01
NCT01441999 ↗Proximal Junctional Kyphosis Following Long Instrumented Spinal Fusion: The Effect of Implant Selection
Kyphosis
NAWithdrawn2016-12-01
NCT01198470 ↗TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study
Lumbar Degenerative Disc Disease
NACompleted2016-12-01
NCT02075554 ↗Study of an Expandable Interbody Device for the Lumbar Spine
Degenerative Disc Disease
NACompleted2016-11-01
NCT02184520 ↗A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System
Acute Instabilities Thoracic, Lumbar and Sacral Spine, Chronic Instabilities Thoracic, Lumbar and Sacral Spine
NATerminated2016-10-20
NCT02299323 ↗INDEPENDENCE Spacer for Lumbar Fusion
Degenerative Disc Disease
—Completed2016-08-01
NCT01156675 ↗Study Evaluating the Safety and Effectiveness of the FLEXUS(TM) Interspinous Spacer
Lumbar Spinal Stenosis
NATerminated2015-07-01
NCT02388022 ↗A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-up.
Degenerative Disc Disease
—Completed2015-01-01
NCT00882661 ↗SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study
Symptomatic Cervical Disc Disease
NACompleted2010-04-01

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Notable events (8-K)

DateItems
2026-06-04Exec/director changeShareholder voteExhibitsfiling ↗
2026-05-07ResultsExhibitsfiling ↗
2026-03-23Exec/director changeReg FDExhibitsfiling ↗
2026-02-24ResultsExhibitsfiling ↗
2026-01-07ResultsExhibitsfiling ↗
2025-11-06ResultsExhibitsfiling ↗
2025-08-07ResultsExhibitsfiling ↗
2025-07-21ResultsExec/director changeReg FDExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-042026-06-030001628280-26-040784 ↗
8-K2026-05-072026-05-070001628280-26-032164 ↗
10-Q2026-05-072026-03-310001628280-26-032290 ↗
8-K2026-03-232026-03-230001628280-26-020612 ↗
10-K2026-02-242025-12-310001628280-26-011209 ↗
8-K2026-02-242026-02-240001628280-26-011124 ↗
8-K2026-01-072026-01-070001628280-26-001189 ↗
8-K2025-11-062025-11-060001237831-25-000029 ↗
10-Q2025-11-062025-09-300001237831-25-000031 ↗
10-Q2025-08-072025-06-300001562762-25-000200 ↗
8-K2025-08-072025-08-070001562762-25-000198 ↗
8-K2025-07-212025-07-180001562762-25-000166 ↗